β-Amyloid neurotoxicity is mediated by a glutamate-triggered excitotoxic cascade in rat nucleus basalis

European Journal of Neuroscience

Volumn 12, Issue 8, 2000, Pages 2735-2745

  Harkany, T ^a,b,c   Abraham I ^d   Timmerman, W ^a   Laskay, G ^e   Toth B ^d   Sasvari M ^c   Konya C ^b   Sebens, J B ^f   Korf, J ^f   Nyakas, C ^c   Zarandi M ^e   Soos K ^e   Penke, B ^e   Luiten, P G M ^a,f  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Trace Element Research Center   (Hungary)

^c SEMMELWEIS UNIVERSITY   (Hungary)

^d INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^e UNIVERSITY OF SZEGED   (Hungary)

^f UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Alzheimer's disease; Calcium; Excitotoxicity; N methyl D aspartate receptor

Indexed keywords

AMYLOID BETA PROTEIN; CALCIUM; DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADOLESCENT; AGED; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CALCIUM CELL LEVEL; CHOLINERGIC NERVE; CONTROLLED STUDY; DEPOLARIZATION; MAGNOCELLULAR NUCLEUS; NERVE CELL NECROSIS; NEUROTOXICITY; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; RAT; SENESCENCE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ASPARTIC ACID; ASTROCYTES; BASAL NUCLEUS OF MEYNERT; CALCIUM; CALCIUM RADIOISOTOPES; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; MICRODIALYSIS; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; NEUROTOXINS; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; TAURINE;

EID: 0033816844     PISSN: 0953816X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9568.2000.00164.x     Document Type: Article

References (67)

1. Administration of amyloid β-peptides into the medial septum of rats decreases acetylcholine release from hippocampus in vivo
2. Oxygen free radicals regulate NMDA receptor function via a redox modulatory site
3. 2+ interaction with Alzheimer amyloid β protein calcium channels
4. β-Amyloid peptides as direct cholinergic neuromodulators: A missing link?
5. Hydrogen peroxide mediates amyloid β protein toxicity
6. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease
7. 3H]MK-801 binding to rat cortical membranes
8. Effects of β-amyloid (25-35) peptides on radioligand binding to excitatory amino acid receptors and voltage-dependent calcium channels: Evidence for a selective affinity for the glutamate and glycine recognition sites of the NMDA receptor
9. Scavenger receptor-mediated adhesion of microglia to β-amyloid fibrils
10. Topography of a binding site for small amnestic peptides deduced from structure-activity studies: Relation to amnestic effect of amyloid β protein
11. Differential localization of NADPH-diaphorase and calbindin-D28k within the cholinergic neurons of the basal forebrain, striatum and brainstem in the rat, monkey, baboon and human
12. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity
13. Differential effects of amyloid peptides β-(1-40) and β-(25-35) injections into the rat nucleus basalis
14. Alzheimer's disease: Initial report on the purification and characterization of a novel cerebrovascular amyloid protein
15. Amyloid β-peptide is produced by cultured cells during normal metabolism
16. Increased amyloid protein precursor and apolipoprotein E immunoreactivity in the selectively vulnerable hippocampus following transient forebrain ischemia in gerbils
17. Mechanisms of β-amyloid neurotoxicity: Perspectives of pharmacotherapy
18. β-Amyloid ((1-42)) affects cholinergic but not parvalbumin-containing neurons in the septal complex of the rat
19. Neuroprotective approaches in experimental models of β-amyloid neurotoxicity: Relevance to Alzheimer's disease
20. Cholinotoxic effects of β-amyloid ((1-42)) peptide on cortical projections of the rat nucleus basalis magnocellularis
21. N-methyl-D-aspartate receptor antagonist MK-801 and radical scavengers protect cholinergic nucleus basalis neurons against β-amyloid neurotoxicity
22. 24)25-35 in rat nucleus basalis induces behavioral dysfunctions, impairs learning and memory and disrupts cortical cholinergic innervation
23. +-dependent glutamate uptake in rat hippocampal astrocyte cultures
24. Selective in vivo fluorescence labelling of cholinergic neurons containing p75(NTR) in the rat basal forebrain
25. Complete and selective cholinergic denervation of the rat neocortex and hippocampus but not amygdala by an immunotoxin against p75 NGF receptor
26. A modified histochemical technique to visualize acetylcholinesterase-containing axons
27. Identification of the major Aβ1-42-degrading catabolic pathway in brain parenchyma: Suppression leads to biochemical and pathological deposition
28. β-Amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices
29. In vivo neurotoxicity of β-amyloid [β(1-40)] and the β (25-35) fragment
30. β-Amyloid binds to p57(NTR) and activates NFκB in human neuroblastoma cells
31. NMDA-dependent superoxide production and neurotoxicity
32. Diffusible, nonfibrillar ligands derived from Aβ1-42 are potent central nervous system neurotoxins
33. 2+](i) in rat astrocytes
34. Thioflavine T interaction with synthetic Alzheimer's disease β-amyloid peptides: Detection of amyloid aggregation in solution
35. Protein measurement with the Folin phenol reagent
36. 2+ antagonist nimodipine, influence of aging and developmental drug treatment
37. Age-related changes in excitatory amino acid receptors in two mouse strains
38. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide
39. Cellular actions of β-amyloid precursor protein and its soluble and fibrillogenic derivatives
40. Modification of ion homeostasis by lipid peroxidation: Roles in neurodegeneration and adaptive plasticity
41. 2+ homeostasis in Alzheimer's disease
42. β-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity
43. Evidence for calcium-reducing and excito-protective roles for the calcium-binding protein calbindin-D28k in cultured hippocampal neurons
44. 3H]MK-801 binding in the Fisher 344 rat brain
45. Co-injection of β-amyloid with ibotenic acid induces synergistic loss of rat hippocampal neurons
46. β-Amyloid-induced cholinergic denervation correlates with enhanced nitric oxide synthase activity in rat cerebral cortex: Reversal by NMDA receptor blockade
47. The inhibitory effects of β-amyloid on glutamate and glucose uptakes by cultured astrocytes
48. The osmotic/calcium stress theory of brain damage: Are free radicals involved?
49. Neurodegeneration induced by β-amyloid peptides, in vitro: The role of peptide assembly state
50. β-Amyloid neurotoxicity in vitro: Evidence of oxidative stress but not protection by antioxidants
51. 3(3) assay for relative potentials as an indicator of real changes
52. Glutamine and glutamate transport in cultured neuronal and glial cells
53. 2+ transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons
54. The molecular pathology of Alzheimer's disease
55. N-methyl-D-aspartate receptor binding in brains of rats at different ages
56. 45Ca autoradiography in cerebral ischemia in the rat
57. 2+ levels in cultured rat astrocytes
58. In vivo neuroprotection against NMDA-induced neurodegeneration by MK-801 and nimodipine: Combined therapy and temporal course of protection
59. 1-42 induced endothelial toxicity
60. An FT-IR study of the beta-amyloid conformation: Standardization of aggregation grade
61. Electrical stimulation of the substantia nigra reticulata: Detection of neuronal extracellular GABA in the ventromedial thalamus and its regulatory mechanism using microdialysis in awake rats
62. Passive avoidance training induces enhanced levels of immunoreactivity for muscarinic acetylcholine receptor and coexpressed PKCγ and MAP-2 in rat cortical neurons
63. Cholinergic and GABAergic neurons in the rat medial septum express muscarinic acetylcholine receptors
64. Neuronal calcium stores
65. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
66. Neurotrophic and neurotoxic effects of amyloid β protein: Reversal by tachykinin neuropeptides